Brief: Prostatype Genomics Q2 Operating Loss Widens To SEK 7.4 Million
Aug 18 (Reuters) - Prostatype Genomics AB PROGEN.ST :
* Q2 REVENUE SEK 7,960 VERSUS SEK 549,005 YEAR AGO
* Q2 OPERATING LOSS SEK 7.4 MILLION VERSUS LOSS SEK 2.4
MILLION
YEAR AGO
Source text for Eikon: ID:nWkr5JSxgk
Further company coverage: PROGEN.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Prostatype Genomics AB
See all newsBrief: Prostatype Genomics Cannot Specify Timing For Final Medicare Decision
Brief: Prostatype Genomics Enters SEK 6.0 Mln Agreement With Vator Securities For To6
Brief: Prostatype Genomics AB H1 2026 Net Sales SEK 457,000
Brief: Prostatype Genomics Resolves On Directed Issue
Brief: Prostatype Genomics To Receive About SEK 47.4 Mln From Rights Issue